The DOI matches its Crossref record.
Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.
Abstract
Dehydroepiandrosterone (DHEA), a major adrenal secretory steroid in humans, was therapeutic when fed in a concentration of 0.4% to C57BL/KsJ mice with either non-insulin-dependent or insulin-dependent diabetes. Genetically diabetic (db/db) mice of both sexes develop obesity and a glucose intolerance and hyperglycemia associated with insulin resistance by 2 mo of age, and exhibit beta-cell necrosis and islet atrophy by 4 mo. In contrast, DHEA feeding initiated between 1 and 4 mo of age, while only moderately effective in preventing obesity, did prevent the other pathogenic changes and effected a rapid remission of hyperglycemia, a preservation of beta-cell structure and function, and an increased insulin sensitivity as measured by glucose tolerance tests. DHEA feeding was also therapeutic to normal C57BL/KsJ male mice made diabetic by multiple low doses of streptozotocin (SZ). While DHEA treatments did not block either the direct cytotoxic action of SZ on beta-cells or the development of insulitis, the steroid significantly moderated the severity of the ensuing diabetes (reduced hyperglycemia and water consumption, and increased plasma insulin and numbers of residual, granulated beta-cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The 70 -95% reduction in the formation of DHEA and DHEA-S by the adrenals during aging results in a dramatic reduction in the formation of androgens and estrogens in peripheral target tissues, which could well be involved in the pathogenesis of age-related diseases such as insulin resistance (307, 308) and obesity (309 -311).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [308]
Citations
Cited by
Sorted by citations
Items 101–200 of 291
Glutathione peroxidase protein expression and activity in human islets isolated for transplantation
Tonooka, N., Oseid, E. A., Zhou, H., Harmon, J. S., & Robertson, R. P. (2007) · Clinical Transplantation · doi:10.1111/j.1399-0012.2007.00736.x · Cited by 50
The Effect of Dehydroepiandrosterone on Liver Metabolites
Casazza, J. P., Schaffer, W. T., & Veech, R. L. (1986) · Journal of Nutrition · doi:10.1093/jn/116.2.304 · Cited by 48
Sato, K., Iemitsu, M., Aizawa, K., & Ajisaka, R. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.02011.x · Cited by 47
Turner, N. C., & Clapham, J. C. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8845-5_2 · Cited by 46
Dehydroepiandrosterone reduces preadipocyte proliferation via androgen receptor
Fujioka, K., Kajita, K., Wu, Z., Hanamoto, T., Ikeda, T., Mori, I., Okada, H., Yamauchi, M., Uno, Y., Morita, H., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00112.2011 · Cited by 43
“Since the presentation by Coleman and colleagues suggested that DHEA administration prevented diabetes in db/db mice, numerous studies have been published (9).”
BackgroundSato, K., Iemitsu, M., Aizawa, K., Mesaki, N., & Fujita, S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00564.2010 · Cited by 46
Fasting-Induced Hepatic Production of DHEA Is Regulated by PGC-1α, ERRα, and HNF4α
Grasfeder, L. L., Gaillard, S. L., Hammes, S. R., Ilkayeva, O., Newgard, C. B., Hochberg, R. B., Dwyer, M. A., Chang, C., & McDonnell, D. P. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0024 · Cited by 48
SUITTERS, A. J., Shaw, S., WALES, M. R., Porter, J. R., LEONARD, J., WOODGER, R., van den Brand, H., Bodmer, M., & Foulkes, R. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00254.x · Cited by 46
Yamashita, R., Saito, T., SATOH, S., Aoki, K., Kaburagi, Y., & Sekihara, H. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.727 · Cited by 44
Effects of Dehydroepiandrosterone in Immunosuppressed Rats Infected with Cryptosporidium parvum
Rasmussen, K. R., Martin, E. G., & Healey, M. C. (1993) · Journal of Parasitology · doi:10.2307/3283571 · Cited by 44
Effect of dehydroepiandrosterone on glucose uptake in cultured human fibroblasts
Nakashima, N., Haji, M., Sakai, Y., Ono, Y., Umeda, F., & Nawata, H. (1995) · Metabolism · doi:10.1016/0026-0495(95)90065-9 · Cited by 43
Stomati, M., Rubino, S., Spinetti, A., Parrini, D., Luisi, S. V., Casarosa, E., Petraglia, F., & Genazzani, A. R. (1999) · Gynecological Endocrinology · doi:10.1080/09513599909167527 · Cited by 41
Metabolism and actions of dehydroepiandrosterone in humans
Nestler, J. E., Clore, J. N., & Blackard, W. G. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90282-a · Cited by 43
Nestler, J. E., & Kahwash, Z. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117487 · Cited by 43
Forbes, K. J., Hagen, M., Glatt, H. R., Hume, R., & Coughtrie, M. W. H. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03585-u · Cited by 43
Antiviral effect of dehydroepiandrosterone on Japanese encephalitis virus infection
Chang, C., Ou, Y., Raung, S., & Chen, C. (2005) · Journal of General Virology · doi:10.1099/vir.0.81123-0 · Cited by 42
“It has been reported to produce beneficial effects in cancer, atherosclerosis, obesity, autoimmune diseases, infections, diabetes and ageing (Coleman et al., 1982; Gordon et al., 1988; Loria et al., 1988; Nestler et al., 1988; Rao et al., 1992; Morales et al., 1994; van Vollenhoven et al., 1994;…”
BackgroundInfluentialKameda, W., Daimon, M., Oizumi, T., Jimbu, Y., Kimura, M., Hirata, A., Yamaguchi, H., Ohnuma, H., Igarashi, M., Tominaga, M., et al. (2005) · Metabolism · doi:10.1016/j.metabol.2004.12.011 · Cited by 42
“Indeed, the association of serum DHEAS levels with insulin resistance has been shown in many human and animal studies [8-16].”
BackgroundKajita, K., Ishizuka, T., Mune, T., Miura, A., Ishizawa, M., Kanoh, Y., Kawai, Y., Natsume, Y., & Yasuda, K. (2002) · Endocrinology · doi:10.1210/en.2002-220039 · Cited by 42
“• DHEA Suppresses PPAR in Adipocytes Endocrinology, January 2003, 144(1):253–259 255”
BackgroundInfluentialEffect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat.
Sourla, A., Flamand, M., Bélanger, A., & Labrie, F. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00052-1 · Cited by 40
Labrie, F., Cusan, L., Gomez, J., Martel, C., Bérubé, R., Bélanger, P., Chaussade, V., Deloche, C., & Leclaire, J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.02.003 · Cited by 39
“This situation has been proposed to be assoiated with age-related diseases, including skin atrophy, insulin esistance [6,7], obesity [8–10], bone loss, vaginal atrophy, type diabetes, loss of muscle mass and strength (see Labrie [11], for eview).”
Background7 Diabetes and adrenal disease
Nestler, J. E., & McClanahan, M. A. (1992) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80169-7 · Cited by 40
Cancer chemoprevention with the adrenocortical steroid dehydroepiandrosterone and structural analogs
Schwartz, A. G., & Pashko, L. L. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240531114 · Cited by 40
Dehydroepiandrosterone, Cancer, and Aging
Schwartz, A. G. (2022) · Aging and Disease · doi:10.14336/ad.2021.0913 · Cited by 42
“These include cancer [6-13], atherosclerosis [14-16], diabetes [17, 18], obesity [19, 20], as well as amelioration of the deleterious effects of”
BackgroundAntiobesity Effects of Etiocholanolones in Diabetes (db), Viable Yellow (Avy), and Normal Mice*
Coleman, D. L. (1985) · Endocrinology · doi:10.1210/endo-117-6-2279 · Cited by 39
Self-citationCleary, M. P., Zabel, T., & Sartin, J. L. (1988) · Journal of Nutrition · doi:10.1093/jn/118.3.382 · Cited by 38
Food intake reduction and immunologic alterations in mice fed dehydroepiandrosterone
Weindruch, R. H., Mcfeeters, G., & Walford, R. L. (1984) · Experimental Gerontology · doi:10.1016/0531-5565(84)90002-0 · Cited by 38
Effect of short-term DHEA administration on liver metabolism of lean and obese rats
Mohan, P. F., & Cleary, M. P. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.1.e1 · Cited by 38
Labrie, F., Bèlanger, A., Labrie, C., Candas, B., Cusan, L., & Gomez, J.-L. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.02.007 · Cited by 36
Muller, S., & Cleary, M. P. (1985) · Metabolism · doi:10.1016/0026-0495(85)90013-7 · Cited by 37
Protective effect of dehydroepiandrosterone against lipid peroxidation in a human liver cell line
Gallo, M., Aragno, M., Gatto, V., Tamagno, E., Brignardello, E., Manti, R., Danni, O., & Boccuzzi, G. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410035 · Cited by 36
“DHEA has been reported to possess beneficial effects on cancer (1‐6), atherosclerosis (7‐9), obesity (10), autoimmune diseases (11), infections (12, 13), diabetes ( 14 , 15) and aging (16).”
BackgroundLayegh, P., Mousavi, Z., Tehrani, D. F., Parizadeh, S. M. R., & Khajedaluee, M. (2016) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.14.4.263 · Cited by 35
“improved glucose tolerance and insulin sensitivity (27).”
Dehydroepiandrosterone (DHEA) ameliorates the insulin sensitivity in older rats
Mukasa, K., Kanesiro, M., Aoki, K., Okamura, J., Saito, T., Satoh, S., & Sekihara, H. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00126-5 · Cited by 34
Fukui, M., Kitagawa, Y., Ose, H., Hasegawa, G., Yoshikawa, T., & Nakamura, N. (2007) · Current Diabetes Reviews · doi:10.2174/157339907779802094 · Cited by 33
“Supplementing their diet with DHEA prevented these pathologic changes and effected rapid remission of hyperglycemia, cell dysfunction, and insulin resistance [56].”
BackgroundGu, S., Ripp, S. L., Prough, R. A., & Geoghegan, T. E. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.722 · Cited by 34
“…DHEA exerts protective effects in rodents against diseases such as cancer and diabetes and has anti-lipidemic effects, lowering levels of triglycerides and cholesterol (Schwartz, 1979; Coleman et al., 1982; Loria et al., 1988; Nestler et al., 1988, 1991; BenNathan et al., 1992; Inano et al., 1995).”
BackgroundDehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period
Teixeira, C. J., Veras, K. M. D. A., & Carvalho, C. R. D. O. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01842-5 · Cited by 32
Medina, M. C., Souza, L. C., Caperuto, L. C., Anhê, G. F., Amanso, A. M., Teixeira, V. P. A., Bordin, S. A., Carpinelli, Â. R., Britto, L. R., Barbieri, R. L., et al. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.12.014 · Cited by 32
Yang, N.-C., Jeng, K.-C. G., Ho, W., Chou, S.-J., & Hu, M. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00180-1 · Cited by 32
Garris, D. R., & Garris, B. L. (2003) · Diabetes · doi:10.2337/diabetes.52.1.51 · Cited by 32
“The severity of these cellular changes mimic the enhanced blood glucose and triglyceride concentrations that continue to increase across successive time periods (7,17,18).”
BackgroundBROWNE, E. S., Porter, J. R., Correa, G., Abadie, J. M., & Svec, F. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90168-v · Cited by 31
Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone
Aoki, K., Nakajima, A., Mukasa, K., et al. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00219-x · Cited by 31
Garris, D. R., West, R. L., & Pekala, P. H. (1986) · The Anatomical Record · doi:10.1002/ar.1092160304 · Cited by 31
Kanazawa, I., Yamaguchi, T., Yamamoto, M., Yamauchi, M., Kurioka, S., Yano, S., & Sugimoto, T. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-130 · Cited by 30
“DHEA is known to improve insulin resistance [6] and to increase insulin secretion from the pancreas [18].”
BackgroundKajita, K., Ishizuka, T., Miura, A., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3677 · Cited by 30
Hobe, G., Hillesheim, H. G., Schön, R., et al. (1994) · Hormone and Metabolic Research · doi:10.1055/s-2007-1001696 · Cited by 30
Ueshiba, H., & Miyachi, Y. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.561 · Cited by 29
DHEA in bone: the role in osteoporosis and fracture healing
Kirby, D. J., Buchalter, D. B., Anil, U., & Leucht, P. (2020) · Archives of Osteoporosis · doi:10.1007/s11657-020-00755-y · Cited by 28
Cheng, M., Shiao, M., Chiu, D. T.-Y., Weng, S.-F., Tang, H.-Y., & Ho, H. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.104 · Cited by 28
Leptin and the genetics of obesity
Clément, K. (1999) · Acta Paediatrica · doi:10.1111/j.1651-2227.1999.tb14351.x · Cited by 28
Ripp, S. L., Falkner, K. C., Pendleton, M. L., Tamási, V., & Prough, R. A. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.1.113 · Cited by 29
“…with DHEA produces many beneficial effects, including chemoprevention in multiple cancer models (Lubet et al., 1998), antiobesity effects (Yen et al., 1977), amelioration of diabetes and systemic lupus erythematosus (Coleman et al., 1982), and enhancement of immune function (Araneo et al., 1995).”
BackgroundMan, L., Park, J. C., Terry, M. J., Mason, J. M., Burrell, W. A., Liu, F., Kimball, B. Y., Moorji, S. M., Lee, J. A., & Breitbart, A. S. (2005) · Annals of Plastic Surgery · doi:10.1097/01.sap.0000168211.76318.fa · Cited by 27
Taniguchi, S., Yanase, T., Kobayashi, K., Takayanagi, R., & Nawata, H. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05902-3 · Cited by 31
Insulin resistance and advancing age: What role for dehydroepiandrosterone sulfate?
Paolisso, G., Ammendola, S., Rotondi, M., Gambardella, A., Rizzo, M. R., Mazziotti, G., Tagliamonte, M. R., Carella, C., & Varricchio, M. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90231-6 · Cited by 27
The Role of Dehydroepiandrosterone (DHEA) in Skeletal Muscle
Sato, K., & Iemitsu, M. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.03.002 · Cited by 26
Huerta-García, E., Ventura-Gallegos, J. L., Victoriano, M. E. C., Montiel‐Dávalos, A., Tinoco-Jaramillo, G., & López‐Marure, R. (2011) · Steroids · doi:10.1016/j.steroids.2011.11.010 · Cited by 26
Dehydroepiandrosterone in adrenal insufficiency and ageing
Bhagra, S., Nippoldt, T. B., & Nair, K. S. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282fc7049 · Cited by 26
Carley, A. N., & Severson, D. L. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6088-9 · Cited by 26
Estrogenic Stimulation of Hypothalamic-Limbic System Metabolism in Ageing Diabetic C57BL/KsJ Mice
Garris, D. R. (1999) · Neuroendocrinology · doi:10.1159/000054445 · Cited by 26
Bhathena, S. J., Berlin, E., Judd, J. T., Nair, P. P., Kennedy, B. W., Jones, J. G., Smith, P. M., Jones, E. Y., Taylor, P. R., & Campbell, W. S. (1989) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/49.5.752 · Cited by 26
“Similarly, DHEA treatment prevents hyperglycemia, islet atrophy, and severity ofdiabetes in diabetic mice (28, 35 ).”
BackgroundFurutama, D., Fukui, R., Amakawa, M., & Ohsawa, N. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00085-9 · Cited by 26
Veras, K. M. D. A., Almeida, F. N., Nachbar, R. T., et al. (2014) · FEBS Open Bio · doi:10.1016/j.fob.2014.01.005 · Cited by 25
“Indeed, experiental evidence from animal models and studies on postmenopausal omen has shown that DHEA supplementation improves insulin senitivity and reduces fat mass gain, and obesity [ 23 –26 ].”
BackgroundAppearance of leptin in wound fluid as a response to injury
Marikovsky, M., Rosenblum, C. I., Faltin, Z., & Friedman‐Einat, M. (2002) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2002.10505.x · Cited by 24
Byrnes, C. K., Khan, F. H., Nass, P. H., et al. (2001) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2001.00341.x · Cited by 25
Differential modulation of ACTH-stimulated cortisol and androstenedione secretion by insulin
Kramer, R. E., Buster, J. E., & Andersen, R. N. (1990) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(90)90111-5 · Cited by 23
Immunological mutants of the mouse
Shultz, L. D. (1991) · American Journal of Anatomy · doi:10.1002/aja.1001910310 · Cited by 24
Dehydroepiandrosterone induced alterations in rat liver carbohydrate metabolism
Mayer, D., Weber, E., Moore, M. A., Letsch, I., Filsinger, E., & Bannasch, P. (1988) · Carcinogenesis · doi:10.1093/carcin/9.11.2039 · Cited by 24
Dehydroepiandrosterone prevents age-associated alterations, increasing insulin sensitivity
Sánchez, J., de Heredia, F. P., Priego, T., Portillo, M. P., Zamora, S., Garaulet, M., & Palou, A. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.10.005 · Cited by 23
“This age-related decline in DHEAS has been inversely related with a number of age-associated diseases, including atherosclerosis [19], non-insulin-dependent diabetes mellitus [20] and obesity [21].”
BackgroundTagawa, N., Minamitani, E., Yamaguchi, Y., & Kobayashi, Y. (2011) · Steroids · doi:10.1016/j.steroids.2011.09.005 · Cited by 22
“In rodents, a number of studies have also shown that DHEA reduced body weight [12], visceral fat [13], and improved glucose [14] and insulin levels [15].”
Kanazawa, I., Yamaguchi, T., & Sugimoto, T. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2011.07.004 · Cited by 23
“On the other hand, DHEA is known to improve the insulin resistance [4] and to increase the insulin secretion frompancreas [36].”
BackgroundCarbohydrate impairment and insulin secretory abnormalities among Macaca mulatta from Cayo Santiago
Howard, C. F., Kessler, M., & Schwartz, S. M. (1986) · American Journal of Primatology · doi:10.1002/ajp.1350110207 · Cited by 23
DISSOCIATION OF ADRENARCHE AND GONADARCHE IN DIABETES MELLITUS
COHEN, H. N., Paterson, K., Wallace, A., Beastall, G. H., Manderson, W. G., & MacCuish, A. C. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00122.x · Cited by 23
Elkind-Hirsch, K. E., Valdes, C. T., McConnell, T. G., & Malinak, L. R. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90401-4 · Cited by 23
Antidiabetic Activity of Green Tea (Thea sinensis L.) in Genetically Type 2 Diabetic Mice
Miura, T., Koike, T., & Ishida, T. (2005) · Eisei kagaku · doi:10.1248/jhs.51.708 · Cited by 22
Increase in hepatic content of oleic acid induced by dehydroepiandrosterone in the rat
Imai, K., Koyama, M., Kudo, N., et al. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00159-8 · Cited by 22
Lardy, H. A., Marwah, A. K., & Marwah, P. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)71009-8 · Cited by 22
Aoki, K., Kikuchi, T., Mukasa, K., Ito, S., Nakajima, A., SATOH, S., OKAMURA, A., & Sekihara, H. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.799 · Cited by 22
Haning, R. V., HACKETT, R. J., Boothroid, R. I., & Canick, J. A. (1990) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(90)90127-e · Cited by 22
Veronese, N., Trevisan, C., RUI, M. D., Bolzetta, F., Maggi, S., Zambon, S., Corti, M. C., Baggio, G., Perissinotto, E., Crepaldi, G., et al. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.09.013 · Cited by 21
“An association between low serum DHEAS concentrations and insulin resistance has been demonstrated in several animal studies (5), and an active role for DHEAS in type 2 diabetes is also supported by experimental evidence of DHEAS administration’s improving glucose tolerance and sensitivity in rodents with diabetes (6,…”
BackgroundRole of first trimester total testosterone in prediction of subsequent gestational diabetes mellitus
Gözükara, Y., Aytan, H., Ertunç, D., Tok, E. C., Demirtürk, F., Şahin, Ş., & Aytan, P. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12525 · Cited by 21
Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice
Aoki, K., Taniguchi, H., Ito, Y., et al. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.10.031 · Cited by 20
Yamada, Y., Sekihara, H., Omura, M., Yanase, T., Takayanagi, R., Mune, T., Yasuda, K., Ishizuka, T., Ueshiba, H., Miyachi, Y., et al. (2007) · Endocrine Journal · doi:10.1507/endocrj.k05-132 · Cited by 20
Lohman, R. F., Yowell, R. L., Barton, S., et al. (1997) · doi:10.1097/00005373-199701000-00013 · Cited by 20
“Dehydroepiandrosterone (DHEA) is a naturally occurring, weakly androgenic, catabolic steroid known to have diverse effects when administered in pharmacologic doses.(10-14) It can prevent progressive ischemic damage in burn models by preserving vascular function in thermally injured tissue.”
BackgroundJahn, M. P., Jacob, M., Gomes, L. F., Duarte, R. F., Araújo, A. S. D. R., Belló‐Klein, A., Ribeiro, M. F. M., & Kucharski, L. C. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.015 · Cited by 19
Fujita, A., Furutama, D., Tanaka, T., et al. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03712-2 · Cited by 19
Takahashi, H., Nakajima, A., & Sekihara, H. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.12.006 · Cited by 19
Altered adrenal and thyroid function in children with insulin-dependent diabetes mellitus
Radetti, G., Paganini, C., Gentili, L., Barbin, F., Pasquino, B., & ZACHMANN, M. (1994) · Acta Diabetologica · doi:10.1007/bf00570367 · Cited by 19
“Dehydroepiandrosterone sulfate (DHEAS), the most abundant, circulating adrenal steroid in the blood, has gained recent interest in view of its beneficial effect on obesity [1], lipids [2], cancer [3], and diabetes in animals [4] and because its administration reduces body fat, total serum cholesterol, and low density…”
BackgroundRelationships between age, dehydro-epiandrosterone sulphate and plasma glucose in healthy men
Thomas, N. (1999) · Age and Ageing · doi:10.1093/ageing/28.2.217 · Cited by 19
“A therapeutic benefit of DHEA preparations in ameliorating streptozotocininduced diabetes mellitus has been clearly demonstrated in laboratory animals [11].”
BackgroundThe Antiobesity Effect of Dehydroepiandrosterone in Castrated or Noncastrated Obese Zucker Male Rats
Taniguchi, S., Yanase, T., Haji, M., Ishibashi, K., Takayanagi, R., & Nawata, H. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00480.x · Cited by 19
Elkind-Hirsch, K. E., Valdés, C. T., McConnell, T. G., & Malinak, L. R. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54172-7 · Cited by 19
Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats
de Heredia, F. P., Sánchez, J., Priego, T., Nicolás, F., Portillo, M. P., Palou, A., Zamora, S., & Garaulet, M. (2008) · Steroids · doi:10.1016/j.steroids.2008.04.011 · Cited by 18
“The steroid hormone dehydroepiandrosterone (DHEA), esides being precursor for sexual hormones, both androgens nd estrogens [13], is thought to have several positive effects tself, such as cancer prevention [14,15], amelioration of cogitive function [16], and also protection against disturbances elated to the metabolic…”
Pahlavani, M. A., & Harris, M. D. (1995) · Immunology Letters · doi:10.1016/0165-2478(95)00057-c · Cited by 18
Garris, D. R. (1989) · The Anatomical Record · doi:10.1002/ar.1092250407 · Cited by 18
Garris, D. R. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0967-6 · Cited by 16
“In the present studies, E2-HRx in females has been shown to moderate effectively the diabetes-associated hyperglycemia and to promote a normalization of tissue metabolic and cytoarchitectural indices, whereas pre-testosterone agents are effective in males (Coleman et al. 1982).”
BackgroundMethodDecreased levels of hepatic epidermal growth factor receptors in obese hyperglycemic rodents.
Blackshear, P. J., Stumpo, D. J., Kennington, E. A., et al. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45361-6 · Cited by 17
Liver composition and lipid metabolism in NZB/W F1 female mice fed dehydroisoandrosterone
Miller, B. C., Ho-Wai, L., Tyler, N. E., et al. (1988) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(88)90091-4 · Cited by 17
Marrero, M., Prough, R. A., Frenkel, R., et al. (1990) · Experimental Biology and Medicine · doi:10.3181/00379727-193-43010 · Cited by 17
Immunological Properties of Dehydroepiandrosterone, Its Conjugates, and Metabolites
Bradlow, H. L., MURPHY, J., & Byrne, J. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07627.x · Cited by 17
Garris, D. R., & Garris, B. L. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-1019-y · Cited by 16
“Of particular interest was the promotion of normal pancreatic insulin levels in E2-HRx db/db mutants concurrent with the reestablishment of islet cell cytoarchitecture (Coleman 1985; Coleman et al. 1984, 1982).”
BackgroundKanazawa, I., Yamaguchi, T., & Sugimoto, T. (2012) · PubMed · doi:10.3275/8033 · Cited by 16
Yamakita, N., Murai, T., Kokubo, Y., Hayashi, M., Akai, A., & Yasuda, K. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01420.x · Cited by 15
“DHEA and DHEA-S have been of increasing interest because of their possible protective roles in diabetes mellitus (Coleman et al., 1982, 1984; Nestler et al., 1989; Nestler, 1995), bone mineral loss (Nawata et al., 1995; Tanaka et al., 1996), arteriosclerosis (Gordon et al., 1988; Bernini et al.,…”
BackgroundKimura, K., Asami, K., & Yamamoto, M. (1997) · Cell Biochemistry and Function · doi:10.1002/(sici)1099-0844(199712)15:4 · Cited by 26
Metadata
- Authors
- Coleman, D. L., Leiter, E. H., & Schwizer, R. W.
- Affiliations
- Jackson Laboratory (US)
- ORCID
- Coleman, D L
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1982-09-01
- Volume
- 31
- Issue
- 9
- Pages
- 830-833
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1998106197
- Cited by
- 317
- References
- 0
- Citations by year
- 2026: 1 · 2023: 2 · 2022: 7 · 2020: 2 · 2019: 2 · 2018: 4 · 2016: 8 · 2015: 6 · 2014: 5 · 2013: 3 · 2012: 8
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- dehydroepiandrosterone, type 2 diabetes, type 1 diabetes, db/db mice, streptozotocin-induced diabetes, insulin resistance, beta-cell function, beta cell necrosis, islet atrophy, hyperglycemia, impaired glucose tolerance, obesity, insulitis, plasma insulin, glucocorticoids
- MeSH terms
- Animals, Blood Glucose, Dehydroepiandrosterone, Diabetes Mellitus, Experimental, Female, Male, Mice, Inbred C57BL, Pancreas, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review